Abstract
Abnormal amniotic fluid volume is associated with increased maternal risk and perinatal morbidity and mortality. Until the advent of ultrasonography, the invasive nature of amniotic fluid volume assessment limited its clinical utility. Refinements in quantifying the noninvasive sonographic assessment of oligohydramnios and hydramnios have improved the ability of clinicians to identify at-risk pregnancies. This article reviews the available methods of amniotic fluid volume assessment and outlines a comprehensive approach to sonographic screening and monitoring.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Obstetrics and Gynecology Clinics of North America
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
